Consilium Wealth Advisory’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-7,618
Closed -$954K 103
2025
Q4
$954K Buy
7,618
+61
+0.8% +$7.77K 0.35% 44
2025
Q3
$1.01M Buy
7,557
+102
+1% +$13.4K 0.39% 42
2025
Q2
$1.01M Buy
7,455
+3,633
+95% +$479K 0.43% 39
2025
Q1
$507K Buy
3,822
+78
+2% +$9.93K 0.25% 60
2024
Q4
$423K Hold
3,744
0.2% 65
2024
Q3
$427K Hold
3,744
0.23% 59
2024
Q2
$389K Sell
3,744
-9,292
-71% -$985K 0.21% 60
2024
Q1
$1.48M Buy
13,036
+5,994
+85% +$687K 0.83% 27
2023
Q4
$775K Buy
7,042
+461
+7% +$46.1K 0.47% 40
2023
Q3
$637K Buy
6,581
+209
+3% +$22K 0.45% 44
2023
Q2
$695K Buy
6,372
+514
+9% +$54.8K 0.48% 41
2023
Q1
$593K Sell
5,858
-384
-6% -$40.5K 0.51% 38
2022
Q4
$685K Sell
6,242
-2,088
-25% -$216K 0.58% 38
2022
Q3
$806K Sell
8,330
-644
-7% -$68.6K 0.9% 28
2022
Q2
$975K Buy
8,974
+253
+3% +$28.7K 1.05% 26
2022
Q1
$1.03M Buy
8,721
+214
+3% +$26.5K 0.74% 30
2021
Q4
$1.2M Buy
+8,507
New +$1.09M 0.78% 27

Other funds holding ABT

Consilium Wealth Advisory's ABT Position: Q1 2026 in Review

Consilium Wealth Advisory sold out of Abbott (ABT) in Q1 2026, closing a stake of 7,618 shares — an estimated $954K sold.

Consilium Wealth Advisory first reported a position in ABT in Q4 2021 and held it in 17 quarters. The position peaked at $1.48M in Q1 2024. 3,090 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Consilium Wealth Advisory reported no remaining Abbott position as of Q1 2026 after selling out during the quarter.
  • Consilium Wealth Advisory sold 7,618 Abbott shares in Q1 2026, an estimated $954K.
  • Consilium Wealth Advisory first reported a position in Abbott in Q4 2021 and held it in 17 quarters.
  • Consilium Wealth Advisory's Abbott position peaked at $1.48M in Q1 2024.
  • 3,090 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Consilium Wealth Advisory's 13F filing for Q1 2026, filed 20 Apr 2026.